NIKKEI 225
38,835.10 +599.03 (+1.57%) HANG SENG
18,479.37 -98.93 (-0.53%) CRUDE OIL
78.31 -0.07 (-0.09%) GOLD FUTURES
2,323.40 -0.80 (-0.03%) DOW
38,884.26 +31.99 (+0.08%) Bitcoin GBP
49,906.79 -647.62 (-1.28%)
IRWD Dec 2024 10.000 call
| Previous close | 0.7700 |
| Open | 0.9000 |
| Bid | 0.5500 |
| Ask | 1.0000 |
| Strike | 10.00 |
| Expiry date | 2024-12-20 |
| Day's range | 0.7700 - 0.9000 |
| Contract range | N/A |
| Volume | |
| Open interest | 139 |
Business WireIronwood Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference
BOSTON, May 06, 2024--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that management will participate in a fireside chat at The Citizens JMP Life Sciences Conference on Monday, May 13, 2024 at 10:00 a.m. ET at the New York Hilton Midtown.
ZacksEarnings Preview: Ironwood Pharmaceuticals (IRWD) Q1 Earnings Expected to Decline
Ironwood (IRWD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Business WireIronwood Pharmaceuticals to Present New Data on Once-Weekly Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF) at Digestive Disease Week® 2024
BOSTON, May 01, 2024--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, announced today that the company will present new data from studies evaluating apraglutide in adults with short bowel syndrome with intestinal failure (SBS-IF), a condition in which patients are dependent on parenteral support (PS), during the 2024 Digestive Disease Week® (DDW) meeting. DDW is held from May 18-21, 2024, in Washington, D.C.
